These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

578 related items for PubMed ID: 19293593

  • 1. Clinical interpretation of reticulocyte hemoglobin content, RET-Y, in chronic hemodialysis patients.
    Ng HY, Chen HC, Pan LL, Tsai YC, Hsu KT, Liao SC, Chuang FR, Chen JB, Lee CT.
    Nephron Clin Pract; 2009; 111(4):c247-52. PubMed ID: 19293593
    [Abstract] [Full Text] [Related]

  • 2. Soluble transferrin receptors and reticulocyte hemoglobin concentration in the assessment of iron deficiency in hemodialysis patients.
    Fusaro M, Munaretto G, Spinello M, Rebeschini M, Amici G, Gallieni M, Piccoli A.
    J Nephrol; 2005; 18(1):72-9. PubMed ID: 15772926
    [Abstract] [Full Text] [Related]

  • 3. Usefulness of measuring reticulocyte hemoglobin equivalent in the management of haemodialysis patients with iron deficiency.
    Miwa N, Akiba T, Kimata N, Hamaguchi Y, Arakawa Y, Tamura T, Nitta K, Tsuchiya K.
    Int J Lab Hematol; 2010 Apr; 32(2):248-55. PubMed ID: 19624802
    [Abstract] [Full Text] [Related]

  • 4. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC, Hung SC, Tarng DC.
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [Abstract] [Full Text] [Related]

  • 5. Monitoring the content of reticulocyte hemoglobin (CHr) as the progression of anemia in nondialysis chronic renal failure (CRF) patients.
    Tsuchiya K, Saito M, Okano-Sugiyama H, Nihei H, Ando M, Teramura M, Iwamoto YS, Shimada K, Akiba T.
    Ren Fail; 2005 Jun; 27(1):59-65. PubMed ID: 15717636
    [Abstract] [Full Text] [Related]

  • 6. Ret-Y a measure of reticulocyte size: a sensitive indicator of iron deficiency anemia.
    Kickler TS, Borowitz MJ, Thompson RE, Charintranont N, Law R.
    Clin Lab Haematol; 2004 Dec; 26(6):423-7. PubMed ID: 15596002
    [Abstract] [Full Text] [Related]

  • 7. Reticulocyte hemoglobin equivalent: an indicator of reduced iron availability in chronic kidney diseases during erythropoietin therapy.
    Garzia M, Di Mario A, Ferraro E, Tazza L, Rossi E, Luciani G, Zini G.
    Lab Hematol; 2007 Dec; 13(1):6-11. PubMed ID: 17353176
    [Abstract] [Full Text] [Related]

  • 8. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A, Karkar A, Abdelrahman M.
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
    [Abstract] [Full Text] [Related]

  • 9. Erythropoiesis activity, iron availability and reticulocyte hemoglobinization during treatment with hemodialysis and in subjects with uremia.
    Schoorl M, Schoorl M, Nubé MJ, Bartels PC.
    Clin Lab; 2006 Mar; 52(11-12):621-9. PubMed ID: 17175894
    [Abstract] [Full Text] [Related]

  • 10. [Measuring the content of reticulocyte hemoglobin (CHr) in predialysis chronic renal failure (CRF) patients].
    Saito M, Tsuchiya K, Ando M, Akiba T, Nihei H.
    Nihon Jinzo Gakkai Shi; 2003 Jul; 45(5):430-8. PubMed ID: 14509218
    [Abstract] [Full Text] [Related]

  • 11. Soluble transferrin receptor is correlated with erythropoietin sensitivity in dialysis patients.
    Daschner M, Mehls O, Schaefer F.
    Clin Nephrol; 1999 Oct; 52(4):246-52. PubMed ID: 10543327
    [Abstract] [Full Text] [Related]

  • 12. Comparison of reticulocyte hemoglobin equivalent with traditional markers of iron and erythropoiesis in pediatric dialysis.
    Davidkova S, Prestidge TD, Reed PW, Kara T, Wong W, Prestidge C.
    Pediatr Nephrol; 2016 May; 31(5):819-26. PubMed ID: 26667237
    [Abstract] [Full Text] [Related]

  • 13. Diagnosis of iron deficiency in patients undergoing hemodialysis.
    Buttarello M, Pajola R, Novello E, Rebeschini M, Cantaro S, Oliosi F, Naso A, Plebani M.
    Am J Clin Pathol; 2010 Jun; 133(6):949-54. PubMed ID: 20472854
    [Abstract] [Full Text] [Related]

  • 14. Reticulocyte indices in patients with end stage renal disease on hemodialysis.
    Bhandari S, Turney JH, Brownjohn AM, Norfolk D.
    J Nephrol; 1998 Jun; 11(2):78-82. PubMed ID: 9589378
    [Abstract] [Full Text] [Related]

  • 15. [Clinical usefulness of reticulocyte hemoglobin equivalent (RET-He) in patients at the pre-dialysis stage and in patients on peritoneal dialysis].
    Eguchi A, Tsuchiya K, Tsukada M, Nitta K.
    Nihon Jinzo Gakkai Shi; 2010 Jun; 52(2):132-40. PubMed ID: 20415234
    [Abstract] [Full Text] [Related]

  • 16. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
    El-Khatib M, Duncan HJ, Kant KS.
    Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552
    [Abstract] [Full Text] [Related]

  • 17. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N, Osman-Malik Y, Frinak S, Besarab A.
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [Abstract] [Full Text] [Related]

  • 18. Innovative parameters RET-Y, sTfR, and sTfR-F index in patients with microcytic, hypochromic anemia--their special value for hemoglobinopathies.
    Agorasti A, Trivellas T, Papadopoulos V, Konstantinidou D.
    Lab Hematol; 2007 Apr; 13(2):63-8. PubMed ID: 17573284
    [Abstract] [Full Text] [Related]

  • 19. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H, Wang SX.
    Blood Purif; 2008 Apr; 26(2):151-6. PubMed ID: 18212498
    [Abstract] [Full Text] [Related]

  • 20. The new reticulocyte parameter (RET-Y) of the Sysmex XE 2100: its use in the diagnosis and monitoring of posttreatment sideropenic anemia.
    Buttarello M, Temporin V, Ceravolo R, Farina G, Bulian P.
    Am J Clin Pathol; 2004 Apr; 121(4):489-95. PubMed ID: 15080300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.